-

Wiley Acquires Bio-Rad’s Informatics Spectroscopy Software and Spectral Databases

Latest Acquisition Enhances Wiley Science Solutions Furthering Laboratory Impact

HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB), a global leader in research and education, today announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases. The acquisition adds expertise, content, and powerful software to Wiley’s Science Solutions segment. Terms of the agreement are not disclosed.

“Laboratory-generated data is at the heart of all research. We welcome these new spectroscopy products and services that will help enhance the Wiley Science Solutions portfolio,” said Judy Verses, Executive Vice President, Wiley Research. “These software and spectral libraries are invaluable interpretation tools for researchers who are making an impact in laboratories ranging from environmental to pharmaceutical, and from aerospace to toxicology.”

As one of the largest providers of spectral libraries in mass spectrometry and long-standing partner of Wiley, Bio-Rad’s Sadtler spectra databases in IR, Raman, UV-Vis and NMR allows Wiley to expand its offering in the spectroscopy market. With the acquisition of Bio-Rad’s KnowItAll desktop spectroscopy data system (SDS), server SDS, web-server SDS and ChemWindow chemical structure drawing software, Wiley is poised to enhance its support in vital areas of research data interpretation.

Wiley Science Solutions has been a trusted partner in publishing empirical, experimental, and validated data for laboratory solutions, aiming to improve the quality of chemical analysis and identification through spectral libraries and providing researchers with high-quality data collections to reduce errors and increase productivity in analytical, environmental, food, medicinal, and toxicology laboratories.

This acquisition underscores Wiley’s commitment to investing in technology-based solutions that support the important research and development taking place in government, university and commercial labs around the world.

BIO-RAD, CHEMWINDOW, and KNOWITALL are trademarks of Bio-Rad Laboratories, Inc. in certain jurisdictions. All trademarks used herein are the property of their respective owner.

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.

Contacts

Wiley Investor Relations:
Brian Campbell, +1 201 748 6874
brian.campbell@wiley.com

Media Relations:
Dawn Peters (US): +1 781 388 8408
newsroom@wiley.com
Follow us on Twitter @WileyNews

John Wiley and Sons Inc.

NYSE:WLY
Details
Headquarters: Hoboken, New Jersey
CEO: Matthew Kissner
Employees: 7,000
Organization: PUB

Release Versions

Contacts

Wiley Investor Relations:
Brian Campbell, +1 201 748 6874
brian.campbell@wiley.com

Media Relations:
Dawn Peters (US): +1 781 388 8408
newsroom@wiley.com
Follow us on Twitter @WileyNews

More News From John Wiley and Sons Inc.

Wiley Convenes Experts to Discuss How Stronger Science Communications, Academic Societies Can Strengthen Public Trust

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley launches a new season of "The Conversations," the company's award-winning expert roundtable series....

Wiley Launches Interoperable Platform to Power Scientific Discovery in World's Leading AI Technologies

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley today launched the AI Gateway, which brings trusted research content from scholarly publishers into leading AI tools through a single endpoint....

AI Adoption Jumps to 84% Among Researchers as Expectations Undergo Significant 'Reality Check'

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced key findings from its second ExplanAItions study, revealing a major course correction taking place. The comprehensive study of more than 2,400 researchers worldwide finds that researchers remain optimistic about AI, with 85% reporting that it has improved their efficiency, and close to three-quarters saying it has enhanced both the quantity and quality of their...
Back to Newsroom